NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
2.450
-0.620 (-20.20%)
Oct 19, 2026, 11:55 AM EDT - Market open
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $4.53 million as of October 19, 2026. It is the 44,442nd most valuable company in the world and the 5,945th biggest in the United States. Its market cap has decreased by 84.80% in one year.
Market Cap
4.53M
Enterprise Value
4.53M
1-Year Change
-84.80%
Global Rank
Country Rank
#5,945 United States
Category
ChartMarket Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $4.53M, a decrease of -92.99%. That is a compound annual growth rate of -42.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 4.53M | -80.17% |
| Dec 31, 2025 | 22.84M | -17.70% |
| Dec 31, 2024 | 27.75M | 158.68% |
| Dec 29, 2023 | 10.73M | -24.68% |
| Dec 30, 2022 | 14.24M | -46.24% |
| Dec 31, 2021 | 26.49M | -59.00% |
| Dec 9, 2021 | 64.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alzamend Neuro | 6.27M |
| Enveric Biosciences | 6.18M |
| Evogene | 6.08M |
| Niki BioSolutions | 5.97M |
| Can-Fite BioPharma | 5.94M |
| Acurx Pharmaceuticals | 5.80M |
| Imunon | 5.72M |
| Traws Pharma | 5.68M |